1. Home
  2. USNA vs OCGN Comparison

USNA vs OCGN Comparison

Compare USNA & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$22.13

Market Cap

371.5M

Sector

Health Care

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.71

Market Cap

387.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
OCGN
Founded
1992
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
371.5M
387.3M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
USNA
OCGN
Price
$22.13
$1.71
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$36.00
$7.00
AVG Volume (30 Days)
134.8K
5.7M
Earning Date
02-17-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$912,670,000.00
$5,370,000.00
Revenue This Year
$9.80
$35.88
Revenue Next Year
N/A
N/A
P/E Ratio
$24.40
N/A
Revenue Growth
5.88
14.26
52 Week Low
$18.48
$0.52
52 Week High
$38.32
$1.96

Technical Indicators

Market Signals
Indicator
USNA
OCGN
Relative Strength Index (RSI) 68.10 58.56
Support Level $20.19 $1.58
Resistance Level $21.35 $1.96
Average True Range (ATR) 0.70 0.15
MACD 0.25 0.02
Stochastic Oscillator 92.57 60.16

Price Performance

Historical Comparison
USNA
OCGN

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: